Core Active Ingredients and Therapeutic Targets of Yiguanjian for Liver Fibrosis: A Computational and Genetic Inference-based Study
Gastroenterology & Hepatology Research · 30.06.2026 · 8 (1) · e00001
DOI: 10.14218/ghr.2026.00001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology & Hepatology Research, online erschienen am 15.05.2026. Verfasst von Yikun Jiang und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jiang, Y., Wang, J., Wang, L., Zheng, Y., Zhao, T., Zhang, R., & Xiao, H. (2026). Core Active Ingredients and Therapeutic Targets of Yiguanjian for Liver Fibrosis: A Computational and Genetic Inference-based Study. Gastroenterology & Hepatology Research, 8(1), e00001. https://doi.org/10.14218/ghr.2026.00001
Vancouver
Jiang Y, Wang J, Wang L, Zheng Y, Zhao T, Zhang R, et al. Core Active Ingredients and Therapeutic Targets of Yiguanjian for Liver Fibrosis: A Computational and Genetic Inference-based Study. Gastroenterology & Hepatology Research. 2026;8(1):e00001. doi:10.14218/ghr.2026.00001
BibTeX
@article{Jiang2026,
author = {Jiang, Yikun and Wang, Jiahui and Wang, Lei and Zheng, Yang and Zhao, Tiejian and Zhang, Rongwu and Xiao, Huaye},
title = {Core Active Ingredients and Therapeutic Targets of Yiguanjian for Liver Fibrosis: A Computational and Genetic Inference-based Study},
journal = {Gastroenterology & Hepatology Research},
year = {2026},
volume = {8},
number = {1},
pages = {e00001},
doi = {10.14218/ghr.2026.00001}
}
EUVIMED